-
Now that there are better treatments for hepatitis C in adults, doctors hope the drugs soon will be approved for use in children who were infected at birth. But many at-risk infants don't get tested.
-
Private insurers billed California $387.5 million to treat just 3,624 patients with new medications for hepatitis C. The people are covered by the state's Medicaid program.
-
A Senate investigation finds that Medicaid programs in 33 states spent more than $1 billion on the hepatitis C drug Sovaldi in a single year.